A novel prednisone premedication protocol significantly decreases infusion‑related reactions of rituximab in newly diagnosed diffuse large B‑cell lymphoma

Rituximab is a widely used anti-CD20 monoclonal antibody with a high incidence of infusion-related reactions (IRRs) during administration. Reducing the incidence of IRRs remains problematic in hematological practices. In the present study, a novel strategy of a prednisone pretreatment regimen was de...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Jianghua, Leng, Zhaohui, Gu, Hong, Jing, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189846/
https://www.ncbi.nlm.nih.gov/pubmed/37205922
http://dx.doi.org/10.3892/ol.2023.13844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189846/
https://www.ncbi.nlm.nih.gov/pubmed/37205922
http://dx.doi.org/10.3892/ol.2023.13844

Ejemplares similares